- Home
- WSBF vs VNDA Comparison
WSBF vs VNDA Comparison
Compare WSBF & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBF | VNDA |
|---|---|---|
| Founded | 1921 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 354.9M | 361.4M |
| IPO Year | 2013 | 2005 |
Fundamental Metrics
Financial Performance| Metric | WSBF | VNDA |
|---|---|---|
| Price | $20.17 | $5.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $14.90 |
| AVG Volume (30 Days) | 88.3K | ★ 844.1K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | ★ 46.53 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | N/A | ★ $216,105,000.00 |
| Revenue This Year | N/A | $21.35 |
| Revenue Next Year | N/A | $37.40 |
| P/E Ratio | $57.21 | ★ N/A |
| Revenue Growth | N/A | ★ 8.72 |
| 52 Week Low | $13.08 | $4.14 |
| 52 Week High | $21.03 | $9.91 |
Technical Indicators
Market Signals| Indicator | WSBF | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 58.76 | 30.33 |
| Support Level | $17.78 | $5.11 |
| Resistance Level | $21.03 | $5.58 |
| Average True Range (ATR) | 0.51 | 0.24 |
| MACD | -0.04 | -0.08 |
| Stochastic Oscillator | 90.37 | 0.00 |
Price Performance
Historical ComparisonAbout WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.